Easywell Biomedicals, Inc. (TPEX:1799)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
30.00
+0.05 (0.17%)
Sep 8, 2026, 12:23 PM CST

Easywell Biomedicals Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
360.95281.06325.67262.91159.03153.03
Short-Term Investments
97.87130.2120.2785.12180.51271.24
Trading Asset Securities
23.4540.4320.16--15.01
Cash & Short-Term Investments
482.26451.69466.1348.03339.54439.28
Cash Growth
27.44%-3.09%33.92%2.50%-22.71%90.50%
Accounts Receivable
29.5839.1342.4566.9320.4830.58
Other Receivables
2.6126.8815.511.383.523.23
Receivables
32.1966.0157.9668.3123.9933.82
Inventory
169.78158.54259.2642.1726.8320.55
Prepaid Expenses
19.6923.7834.8849.1222.0916.45
Other Current Assets
2.44-----
Total Current Assets
706.36700.01818.2507.64412.44510.09
Property, Plant & Equipment
466.16487.21545.49542.2572.71555.54
Long-Term Investments
35.430.060.060.060.06-
Other Intangible Assets
77.47101.24136.52156.1168.44179.84
Other Long-Term Assets
6.513.785.047.819.518.44
Total Assets
1,2921,2921,5051,2141,1731,264

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
42.818.2245.639.422.360.47
Short-Term Debt
55.1289.92201.0943.27--
Current Portion of Leases
26.824.4920.7312.6311.479.86
Current Unearned Revenue
50.668.533.7439.834.1911.75
Other Current Liabilities
88.587.11122.5122.4516.114.11
Total Current Liabilities
263.83278.23423.71127.5764.1136.18
Long-Term Leases
304.62311.51342.46330.45338.48315.64
Other Long-Term Liabilities
---131.97--
Total Liabilities
568.45589.74766.17589.99402.6351.82

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,2471,2471,2181,1591,1441,634
Additional Paid-In Capital
43.9188.97132.9835.41.1190.87
Retained Earnings
-607.93-760.93-654.35-570.16-422.31-841.21
Comprehensive Income & Other
26.4115.7422.07-11.0916.01-9.8
Total Common Equity
709.28690.67718.61612.81738.46873.66
Minority Interest
14.1911.8820.5310.9832.138.44
Shareholders' Equity
723.47702.56739.14623.8770.56912.09
Total Liabilities & Equity
1,2921,2921,5051,2141,1731,264

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
386.54425.91564.28386.34349.96325.5
Net Cash (Debt)
95.7225.78-98.19-38.31-10.42113.78
Net Cash Growth
------
Net Cash Per Share
0.770.21-0.82-0.33-0.091.10
Filing Date Shares Outstanding
124.69124.69121.79115.87114.37114.37
Total Common Shares Outstanding
124.69124.69121.79115.87114.37114.37
Working Capital
442.53421.78394.49380.07348.33473.91
Book Value Per Share
5.695.545.905.296.467.64
Tangible Book Value
631.82589.44582.09456.72570.02693.81
Tangible Book Value Per Share
5.074.734.783.944.986.07
Machinery
538.83529.8535.61487.94481.86462.27